EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of sustained-release metformin hydrochloride matrix tablets using blends of chitosan and xanthan

Oday Alsawad, Ahmed Abduljabbar

Tropical Journal of Pharmaceutical Research · 06.06.2026 · 25 (5)

DOI: 10.4314/tjpr.v25i5.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tropical Journal of Pharmaceutical Research, online erschienen am 06.06.2026. Verfasst von Oday Alsawad und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To develop sustained-release metformin matrix tablets using chitosan and xanthan, and to compare their performance with hydroxypropyl methylcellulose (HPMC; K100M) matrix and a commercial sustained-release (SR) product.

Method

Metformin matrix tablet formulations were prepared by direct compression of chitosan-xanthan blends at ratios of 1:0 to 0:1, developed based on a 3x2-factorial design (polymer levels 25 – 35 % w/w). A formulation based on HPMC K100M (30 % w/w) and a commercial product were used as controls. Formulated tablets were tested for pre- and post-compression characteristics, swelling/erosion, in vitro dissolution, release kinetics and accelerated stability.

Results

All blends showed fair to good flow (angle of repose 27.9 – 33.8°, Hausner ratio ≤ 1.24), friability (< 0.6 %) and content uniformity (98.1 – 101.3 %). Increasing polymer level and xanthan proportion slowed metformin release. Optimised 30 % chitosan: xanthan (1:1) matrix released 95.2 % metformin content after 12 h, closely matching HPMC formulation (96.0 %), and commercial SR product (f2 = 67). The optimized product (F5) release fitted Higuchi/Korsmeyer-Peppas models (R2 ≥ 0.99; n = 0.63), indicating anomalous diffusion. Stability testing showed no significant changes in all parameters tested (p > 0.05).

Conclusion

Chitosan-xanthan matrices, especially the 1:1 mixture at 30 % w/w, produce stable metformin SR tablets with dissolution behaviour equal to those of HPMC and a commercially available SR metformin product, suggesting their use as alternatives to synthetic/semi-synthetic polymers in once-daily metformin dosage forms.

Zitieren

APA

Alsawad, O., & Abduljabbar, A. (2026). Evaluation of sustained-release metformin hydrochloride matrix tablets using blends of chitosan and xanthan. Tropical Journal of Pharmaceutical Research, 25(5). https://doi.org/10.4314/tjpr.v25i5.2

Vancouver

Alsawad O, Abduljabbar A. Evaluation of sustained-release metformin hydrochloride matrix tablets using blends of chitosan and xanthan. Tropical Journal of Pharmaceutical Research. 2026;25(5). doi:10.4314/tjpr.v25i5.2

BibTeX
@article{Alsawad2026,
  author = {Alsawad, Oday and Abduljabbar, Ahmed},
  title = {Evaluation of sustained-release metformin hydrochloride matrix tablets using blends of chitosan and xanthan},
  journal = {Tropical Journal of Pharmaceutical Research},
  year = {2026},
  volume = {25},
  number = {5},
  doi = {10.4314/tjpr.v25i5.2}
}
Kostenlos starten →